Novel Blood Test May Detect Cancer

Novel Blood Test May Detect Cancer

Researchers at the Johns Hopkins Kimmel Cancer Center are developing a new machine learning blood test that detects cancer. The blood testing technology — called GEMINI (Genome-wide Mutational Incidence for Non-Invasive detection of cancer) — combines genome-wide sequencing of single molecules of DNA shed from tumors with machine learning. Investigators found that this test, when followed by computerized tomography imaging, detected over 90% of lung cancers, including among patients with stage I and II disease. Read more about this innovative test here.

SEE ALL NEWS
Recent Posts
Study Suggests a Healthy Diet May Help Keep Low Grade Prostate Cancer From Progressing to More Dangerous States During Active Surveillance Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models Johns Hopkins Joins Cancer AI Alliance AI ‘Liquid Biopsies’ Using Cell-Free DNA, Protein Biomarkers, Could Aid Early Detection of Ovarian Cancer A Common Culprit Drives Prostate Cancer Progression Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence Age-Related Changes in Male Fibroblasts Increase Treatment-Resistant Melanoma Scientists Identify Potential New Immune System Target to Head Off the Spread of Breast Cancer Cells Johns Hopkins Researchers Identify Key Markers in Pancreatic Cancer Progression Using a New Analysis Pipeline